BioCryst Pharmaceuticals Inc. (BCRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BioCryst Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
BioCryst Pharmaceuticals Inc. (BCRX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $2.1B. It trades at $8.37, up 3.33% today. Its overall quality score is 64 out of 100, ranked against the whole US market. 7 analysts' average target of $19.25 implies +130.0% from today's price. Kronos AI's 30-day forecast is +12.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $19.25 |
| Low – high | $11.00 – $32.00 |
| Analysts | 7 |
| Upside to average | +130.0% |
Kronos AI 30-day forecast
| Expected close | $9.08 (+12.1%) |
| Likely range | +5.2% … +20.3% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 53 |
| Solvency | 51 |
| Growth | 89 |
| Overall | 64 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator